Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Activity And Safety Of Nivolumab, An Anti-PD-1 Immune Checkpoint Inhibitor, For Patients With Advanced, Refractory Squamous Non-small-cell Lung Cancer (CheckMate 063): A Phase 2, Single-arm Trial

Naiyer A Rizvi, Julien Mazières, David Planchard, Thomas E Stinchcombe, Grace K Dy, Scott J Antonia, Leora Horn, Hervé Lena, Elisa Minenza, Bertrand Mennecier, Gregory A Otterson, Luis T Campos, David R Gandara, Benjamin P Levy, Suresh G Nair, Gérard Zalcman, Jürgen Wolf, Pierre-Jean Souquet, Editta Baldini, Federico Cappuzzo, Christos Chouaid, Afshin Dowlati, Rachel Sanborn, Ariel Lopez-Chavez, Christian Grohe, Rudolf M Huber, Christopher T Harbison, Christine Baudelet, Brian J Lestini, Suresh S Ramalingam

Save to my Library
Download PDF
Analyze on Scholarcy
Share